Chinese Chemical Company, Senior Leaders Indicted for Suspected Fentanyl Manufacturing, Distribution
LOS ANGELES — A joint investigation resulted in charges for Hubei Aoks Bio-Tech Co. Ltd., its director and three senior employees in U.S. federal court Nov. 7, for allegedly selling fentanyl precursor chemicals and xylazine — known as “tranq” — globally.